179 related articles for article (PubMed ID: 29497990)
1. Transmembrane domain dependent inhibitory function of FcγRIIB.
Wang J; Li Z; Xu L; Yang H; Liu W
Protein Cell; 2018 Dec; 9(12):1004-1012. PubMed ID: 29497990
[TBL] [Abstract][Full Text] [Related]
2. Through an ITIM-independent mechanism the FcγRIIB blocks B cell activation by disrupting the colocalized microclustering of the B cell receptor and CD19.
Xu L; Li G; Wang J; Fan Y; Wan Z; Zhang S; Shaheen S; Li J; Wang L; Yue C; Zhao Y; Wang F; Brzostowski J; Chen YH; Zheng W; Liu W
J Immunol; 2014 Jun; 192(11):5179-91. PubMed ID: 24790152
[TBL] [Abstract][Full Text] [Related]
3. FcγRIIB-I232T polymorphic change allosterically suppresses ligand binding.
Hu W; Zhang Y; Sun X; Zhang T; Xu L; Xie H; Li Z; Liu W; Lou J; Chen W
Elife; 2019 Jul; 8():. PubMed ID: 31343409
[TBL] [Abstract][Full Text] [Related]
4. Impairment on the lateral mobility induced by structural changes underlies the functional deficiency of the lupus-associated polymorphism FcγRIIB-T232.
Xu L; Xia M; Guo J; Sun X; Li H; Xu C; Gu X; Zhang H; Yi J; Fang Y; Xie H; Wang J; Shen Z; Xue B; Sun Y; Meckel T; Chen YH; Hu Z; Li Z; Xu C; Gong H; Liu W
J Exp Med; 2016 Nov; 213(12):2707-2727. PubMed ID: 27799621
[TBL] [Abstract][Full Text] [Related]
5. The Lupus-Associated Fcγ Receptor IIb-I232T Polymorphism Results in Impairment in the Negative Selection of Low-Affinity Germinal Center B Cells Via c-Abl in Mice.
Jhou JP; Yu IS; Hwai H; Chen CS; Chen PL; Tzeng SJ
Arthritis Rheumatol; 2018 Nov; 70(11):1866-1878. PubMed ID: 29774664
[TBL] [Abstract][Full Text] [Related]
6. The Unique Inhibitory IgG Receptor--FcγRIIb.
Xu Z; Liu L; Cui Z; Bi K; Zhang N; Zhang Y; Liu Z
Protein Pept Lett; 2018; 25(11):966-972. PubMed ID: 30370842
[TBL] [Abstract][Full Text] [Related]
7. FcgammaRIIB, FcgammaRIIIB, and systemic lupus erythematosus.
Niederer HA; Clatworthy MR; Willcocks LC; Smith KG
Ann N Y Acad Sci; 2010 Jan; 1183():69-88. PubMed ID: 20146709
[TBL] [Abstract][Full Text] [Related]
8. FcgammaRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling.
Kono H; Kyogoku C; Suzuki T; Tsuchiya N; Honda H; Yamamoto K; Tokunaga K; Honda Z
Hum Mol Genet; 2005 Oct; 14(19):2881-92. PubMed ID: 16115811
[TBL] [Abstract][Full Text] [Related]
9. FcγRIIb inhibits immune complex-induced VEGF-A production and intranodal lymphangiogenesis.
Clatworthy MR; Harford SK; Mathews RJ; Smith KG
Proc Natl Acad Sci U S A; 2014 Dec; 111(50):17971-6. PubMed ID: 25475856
[TBL] [Abstract][Full Text] [Related]
10. FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications.
Smith KG; Clatworthy MR
Nat Rev Immunol; 2010 May; 10(5):328-43. PubMed ID: 20414206
[TBL] [Abstract][Full Text] [Related]
11. A novel polymorphism in the Fcgamma receptor IIB (CD32B) transmembrane region alters receptor signaling.
Li X; Wu J; Carter RH; Edberg JC; Su K; Cooper GS; Kimberly RP
Arthritis Rheum; 2003 Nov; 48(11):3242-52. PubMed ID: 14613290
[TBL] [Abstract][Full Text] [Related]
12. FcγRIIB and autoimmunity.
Espéli M; Smith KG; Clatworthy MR
Immunol Rev; 2016 Jan; 269(1):194-211. PubMed ID: 26683154
[TBL] [Abstract][Full Text] [Related]
13. Expression profile of FcgammaRIIb on leukocytes and its dysregulation in systemic lupus erythematosus.
Su K; Yang H; Li X; Li X; Gibson AW; Cafardi JM; Zhou T; Edberg JC; Kimberly RP
J Immunol; 2007 Mar; 178(5):3272-80. PubMed ID: 17312177
[TBL] [Abstract][Full Text] [Related]
14. Antibody-mediated coengagement of FcγRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus.
Horton HM; Chu SY; Ortiz EC; Pong E; Cemerski S; Leung IW; Jacob N; Zalevsky J; Desjarlais JR; Stohl W; Szymkowski DE
J Immunol; 2011 Apr; 186(7):4223-33. PubMed ID: 21357255
[TBL] [Abstract][Full Text] [Related]
15. Suppression of mast cell degranulation through a dual-targeting tandem IgE-IgG Fc domain biologic engineered to bind with high affinity to FcγRIIb.
Cemerski S; Chu SY; Moore GL; Muchhal US; Desjarlais JR; Szymkowski DE
Immunol Lett; 2012 Mar; 143(1):34-43. PubMed ID: 22305932
[TBL] [Abstract][Full Text] [Related]
16. FcgammaRIIB as a modulator of autoimmune disease susceptibility.
Tarasenko T; Dean JA; Bolland S
Autoimmunity; 2007 Sep; 40(6):409-17. PubMed ID: 17729034
[TBL] [Abstract][Full Text] [Related]
17. Defunctioning polymorphism in the immunoglobulin G inhibitory receptor (FcγRIIB-T/T232) does not impact on kidney transplant or recipient survival.
Clatworthy MR; Matthews RJ; Doehler B; Willcocks LC; Opelz G; Smith KGC
Transplantation; 2014 Aug; 98(3):285-291. PubMed ID: 25022320
[TBL] [Abstract][Full Text] [Related]
18. FcγRIIB Gene Polymorphisms Are Associated with Disease Risk and Clinical Manifestations of Systemic Lupus Erythematosus in Koreans.
Jeon JY; Kim KY; Kim BS; Jung JY; Kim HA; Suh CH
Tohoku J Exp Med; 2015 Jul; 236(3):185-91. PubMed ID: 26084639
[TBL] [Abstract][Full Text] [Related]
19. Immune complex enhances tolerogenecity of immature dendritic cells via FcγRIIb and promotes FcγRIIb-overexpressing dendritic cells to attenuate lupus.
Zhang Y; Liu S; Yu Y; Zhang T; Liu J; Shen Q; Cao X
Eur J Immunol; 2011 Apr; 41(4):1154-64. PubMed ID: 21360699
[TBL] [Abstract][Full Text] [Related]
20. Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility.
Kyogoku C; Dijstelbloem HM; Tsuchiya N; Hatta Y; Kato H; Yamaguchi A; Fukazawa T; Jansen MD; Hashimoto H; van de Winkel JG; Kallenberg CG; Tokunaga K
Arthritis Rheum; 2002 May; 46(5):1242-54. PubMed ID: 12115230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
